1. Home
  2. LFVN vs LONA Comparison

LFVN vs LONA Comparison

Compare LFVN & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$6.69

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$9.44

Market Cap

76.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFVN
LONA
Founded
N/A
2011
Country
United States
United States
Employees
N/A
19
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
76.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LFVN
LONA
Price
$6.69
$9.44
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$11.00
$10.00
AVG Volume (30 Days)
851.7K
12.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
3.56%
N/A
EPS Growth
226.09
N/A
EPS
0.30
N/A
Revenue
$203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.17
N/A
Revenue Growth
1.86
N/A
52 Week Low
$3.90
$4.21
52 Week High
$15.00
$14.21

Technical Indicators

Market Signals
Indicator
LFVN
LONA
Relative Strength Index (RSI) 46.50 60.08
Support Level $5.67 $7.94
Resistance Level $11.71 $9.62
Average True Range (ATR) 1.22 0.58
MACD -0.31 0.12
Stochastic Oscillator 19.16 90.26

Price Performance

Historical Comparison
LFVN
LONA

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: